HER2(ErbB2)Antibodies Market Report

China HER2(ErbB2)Antibodies Industry Market Research Report 2023-2029

  • POSTDATE：Sep 02, 2023
  • PAGES：155
  • REPORT CODE：GMM1771882
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the HER2(ErbB2)Antibodies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis AG

    • BioVision Inc,

    • Genentech Inc (F Hoffmann-La Roche Ltd)

    • Pfizer Inc

    • Bio-Techne (Novus Biologicals, LLC)

    • Thermo Fisher Scientific

    • InvivoGen

    • Atlas Antibodies

    • Biocon Limited

    • Cell Signaling Technology (CST)

    • Celltrion Inc

    By Type:

    • Trastuzumab

    • Ado-trastuzumab emtansine

    • Pertuzumab

    • Lapatinib

    • Everolimus

    By Application:

    • Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China HER2(ErbB2)Antibodies Market Overview 2018-2029

    • 1.1 China HER2(ErbB2)Antibodies Industry Development Overview

    • 1.2 China HER2(ErbB2)Antibodies Industry Development History

    • 1.3 China HER2(ErbB2)Antibodies Industry Market Size (2018-2029)

    • 1.4 China HER2(ErbB2)Antibodies Market Analysis by Type from Production Side

      • 1.4.1 China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Trastuzumab (2018-2029)

      • 1.4.2 China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Ado-trastuzumab emtansine (2018-2029)

      • 1.4.3 China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Pertuzumab (2018-2029)

      • 1.4.4 China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Lapatinib (2018-2029)

      • 1.4.5 China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Everolimus (2018-2029)

    • 1.5 China HER2(ErbB2)Antibodies Market Analysis by Application from Consumption End

      • 1.5.1 China HER2(ErbB2)Antibodies Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China HER2(ErbB2)Antibodies Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China HER2(ErbB2)Antibodies Market Analysis by Region

      • 1.6.1 North China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    Chapter 2 China HER2(ErbB2)Antibodies Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on HER2(ErbB2)Antibodies Market Status and Competition at home and abroad in 2023

      • 2.2.2 China HER2(ErbB2)Antibodies Market Status and Competition Analysis in 2023

      • 2.2.3 China HER2(ErbB2)Antibodies Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China HER2(ErbB2)Antibodies Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on HER2(ErbB2)Antibodies Industry Development

    Chapter 3 HER2(ErbB2)AntibodiesIndustry Chain Analysis

    • 3.1 HER2(ErbB2)Antibodies Industry Chain

    • 3.2 HER2(ErbB2)Antibodies Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the HER2(ErbB2)Antibodies Market

    • 3.3 HER2(ErbB2)Antibodies Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the HER2(ErbB2)Antibodies Market

    Chapter 4 China HER2(ErbB2)Antibodies Market, by Type

    • 4.1 China HER2(ErbB2)Antibodies Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China HER2(ErbB2)Antibodies Total Production Volume and Growth Rate from Production Side

    • 4.5 China HER2(ErbB2)Antibodies Production Volume and Growth Rate, by Type

      • 4.5.1 China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Trastuzumab

      • 4.5.2 China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Ado-trastuzumab emtansine

      • 4.5.3 China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Pertuzumab

      • 4.5.4 China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Lapatinib

      • 4.5.5 China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Everolimus

    Chapter 5 China HER2(ErbB2)Antibodies Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China HER2(ErbB2)Antibodies Total Market Size and Growth Rate from Consumption End

    • 5.5 China HER2(ErbB2)Antibodies Market Size and Growth Rate, by Application

      • 5.5.1 China HER2(ErbB2)Antibodies Market Size and Growth Rate of Clinics

      • 5.5.2 China HER2(ErbB2)Antibodies Market Size and Growth Rate of Hospitals

    Chapter 6 China HER2(ErbB2)Antibodies Market, by Region

    • 6.1 China HER2(ErbB2)Antibodies Production Volume and Production Value, by Region

    • 6.2 China HER2(ErbB2)Antibodies Sales Volume and Sales Value, by Region

    Chapter 7 North China HER2(ErbB2)Antibodies Market Analysis

    • 7.1 North China HER2(ErbB2)Antibodies Market, by Type

    • 7.2 North China HER2(ErbB2)Antibodies Market, by Application

    Chapter 8 Central China HER2(ErbB2)Antibodies Market Analysis

    • 8.1 Central China HER2(ErbB2)Antibodies Market, by Type

    • 8.2 Central China HER2(ErbB2)Antibodies Market, by Application

    Chapter 9 South China HER2(ErbB2)Antibodies Market Analysis

    • 9.1 South China HER2(ErbB2)Antibodies Market, by Type

    • 9.2 South China HER2(ErbB2)Antibodies Market, by Application

    Chapter 10 East China HER2(ErbB2)Antibodies Market Analysis

    • 10.1 East China HER2(ErbB2)Antibodies Market, by Type

    • 10.2 East China HER2(ErbB2)Antibodies Market, by Application

    Chapter 11 Northeast China HER2(ErbB2)Antibodies Market Analysis

    • 11.1 Northeast China HER2(ErbB2)Antibodies Market, by Type

    • 11.2 Northeast China HER2(ErbB2)Antibodies Market, by Application

    Chapter 12 Southwest China HER2(ErbB2)Antibodies Market Analysis

    • 12.1 Southwest China HER2(ErbB2)Antibodies Market, by Type

    • 12.2 Southwest China HER2(ErbB2)Antibodies Market, by Application

    Chapter 13 Northwest China HER2(ErbB2)Antibodies Market Analysis

    • 13.1 Northwest China HER2(ErbB2)Antibodies Market, by Type

    • 13.2 Northwest China HER2(ErbB2)Antibodies Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis AG

        • 14.1.1 Novartis AG Company Profile

        • 14.1.2 Novartis AG HER2(ErbB2)Antibodies Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BioVision Inc,

        • 14.2.1 BioVision Inc, Company Profile

        • 14.2.2 BioVision Inc, HER2(ErbB2)Antibodies Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Genentech Inc (F Hoffmann-La Roche Ltd)

        • 14.3.1 Genentech Inc (F Hoffmann-La Roche Ltd) Company Profile

        • 14.3.2 Genentech Inc (F Hoffmann-La Roche Ltd) HER2(ErbB2)Antibodies Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pfizer Inc

        • 14.4.1 Pfizer Inc Company Profile

        • 14.4.2 Pfizer Inc HER2(ErbB2)Antibodies Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bio-Techne (Novus Biologicals, LLC)

        • 14.5.1 Bio-Techne (Novus Biologicals, LLC) Company Profile

        • 14.5.2 Bio-Techne (Novus Biologicals, LLC) HER2(ErbB2)Antibodies Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Thermo Fisher Scientific

        • 14.6.1 Thermo Fisher Scientific Company Profile

        • 14.6.2 Thermo Fisher Scientific HER2(ErbB2)Antibodies Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 InvivoGen

        • 14.7.1 InvivoGen Company Profile

        • 14.7.2 InvivoGen HER2(ErbB2)Antibodies Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Atlas Antibodies

        • 14.8.1 Atlas Antibodies Company Profile

        • 14.8.2 Atlas Antibodies HER2(ErbB2)Antibodies Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Biocon Limited

        • 14.9.1 Biocon Limited Company Profile

        • 14.9.2 Biocon Limited HER2(ErbB2)Antibodies Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Cell Signaling Technology (CST)

        • 14.10.1 Cell Signaling Technology (CST) Company Profile

        • 14.10.2 Cell Signaling Technology (CST) HER2(ErbB2)Antibodies Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Celltrion Inc

        • 14.11.1 Celltrion Inc Company Profile

        • 14.11.2 Celltrion Inc HER2(ErbB2)Antibodies Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 HER2(ErbB2)Antibodies Industry Research Conclusions

    • 15.2 HER2(ErbB2)Antibodies Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China HER2(ErbB2)Antibodies Industry Market Size (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Trastuzumab (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Ado-trastuzumab emtansine (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Pertuzumab (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Lapatinib (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Production Volume, Production Value and Growth Rate of Everolimus (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China HER2(ErbB2)Antibodies Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Central China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure South China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure East China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Northeast China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Southwest China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure Northwest China HER2(ErbB2)Antibodies Market Size and Growth Rate from 2018-2029

    • Figure HER2(ErbB2)Antibodies Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China HER2(ErbB2)Antibodies Market Share by Type in 2018

    • Figure China HER2(ErbB2)Antibodies Market Share by Type in 2023

    • Figure China HER2(ErbB2)Antibodies Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Trastuzumab (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Ado-trastuzumab emtansine (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Pertuzumab (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Lapatinib (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume and Growth Rate of Everolimus (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Market Share by Application in 2018

    • Figure China HER2(ErbB2)Antibodies Market Share by Application in 2023

    • Figure China HER2(ErbB2)Antibodies Total Market Size and Growth Rate from Consumption End

    • Figure China HER2(ErbB2)Antibodies Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China HER2(ErbB2)Antibodies Production Volume by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Production Volume Share by Region (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Volume Share by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Production Value by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Production Value Share by Region (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Production Value Share by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Sales Volume by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Sales Volume Share by Region (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Sales Volume Share by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Sales Value by Region (2018-2023)

    • Table China HER2(ErbB2)Antibodies Sales Value Share by Region (2018-2023)

    • Figure China HER2(ErbB2)Antibodies Sales Value Share by Region (2018-2023)

    • Table North China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table North China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure North China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table North China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table North China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure North China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table Central China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table Central China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure Central China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table Central China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table Central China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Central China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table South China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table South China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure South China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table South China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table South China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure South China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table East China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table East China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure East China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table East China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table East China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure East China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table Northeast China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table Northeast China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure Northeast China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table Northeast China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table Northeast China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Northeast China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table Southwest China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table Southwest China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure Southwest China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table Southwest China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table Southwest China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Southwest China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table Northwest China HER2(ErbB2)Antibodies Production Volume by Type (2018-2023)

    • Table Northwest China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Figure Northwest China HER2(ErbB2)Antibodies Production Volume Share by Type (2018-2023)

    • Table Northwest China HER2(ErbB2)Antibodies Sales Volume by Application (2018-2023)

    • Table Northwest China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Figure Northwest China HER2(ErbB2)Antibodies Sales Volume Share by Application (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table BioVision Inc, Company Profile

    • Table BioVision Inc, HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Genentech Inc (F Hoffmann-La Roche Ltd) Company Profile

    • Table Genentech Inc (F Hoffmann-La Roche Ltd) HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Bio-Techne (Novus Biologicals, LLC) Company Profile

    • Table Bio-Techne (Novus Biologicals, LLC) HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table InvivoGen Company Profile

    • Table InvivoGen HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Atlas Antibodies Company Profile

    • Table Atlas Antibodies HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Biocon Limited Company Profile

    • Table Biocon Limited HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Cell Signaling Technology (CST) Company Profile

    • Table Cell Signaling Technology (CST) HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)

    • Table Celltrion Inc Company Profile

    • Table Celltrion Inc HER2(ErbB2)Antibodies Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US